Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease. - Suppr | 超能文献

Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.

作者信息

Menon C, Berry E W, Ockelford P

出版信息

Lancet. 1978 Sep 30;2(8092 Pt 1):743-4. doi: 10.1016/s0140-6736(78)92749-6.

DOI:10.1016/s0140-6736(78)92749-6

PMID:80674

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.

Lancet. 1978 Sep 30;2(8092 Pt 1):743-4. doi: 10.1016/s0140-6736(78)92749-6.

2

Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.

Ann Intern Med. 1984 Nov;101(5):719-20. doi: 10.7326/0003-4819-101-5-719_3.

3

Use of deamino-8-D arginine vasopressin in a patient with moderate von Willebrand's disease.去氨基-8-D精氨酸加压素在一名中度血管性血友病患者中的应用。

J Oral Maxillofac Surg. 1987 Aug;45(8):728-30. doi: 10.1016/0278-2391(87)90321-1.

4

[Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].

Rinsho Ketsueki. 1979 Apr;20(4):364-71.

5

Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.血管性血友病的病理生理学与治疗研究。V. 去氨基-8-右旋精氨酸加压素输注后变异型血管性血友病中VIII因子的特性。

Thromb Res. 1981;21(4-5):357-65. doi: 10.1016/0049-3848(81)90136-5.

6

[A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].

Rinsho Ketsueki. 1983 Dec;24(12):1674-9.

7

Mild bleeding disorders: review of 120 patients.轻度出血性疾病：120例患者的回顾

Clin Lab Haematol. 1984;6(3):247-56.

8

Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.轻度和中度甲型血友病及血管性血友病患者对去氨加压素治疗的反应。

Ann Intern Med. 1985 Jul;103(1):6-14. doi: 10.7326/0003-4819-103-1-6.

9

DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.

Thromb Res. 1978 Dec;13(6):1119-23. doi: 10.1016/0049-3848(78)90240-2.

10

1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.1-去氨基-8-D-精氨酸加压素——治疗轻度甲型血友病和血管性血友病的一种替代药物。

Wien Klin Wochenschr. 1983 Nov 11;95(21):753-7.

引用本文的文献

1

Impact of Peptide Structure on Colonic Stability and Tissue Permeability.肽结构对结肠稳定性和组织渗透性的影响。

Pharmaceutics. 2023 Jul 15;15(7):1956. doi: 10.3390/pharmaceutics15071956.

2

Desmopressin and the risk of hyponatremia: A population-based cohort study.去氨加压素与低钠血症风险：基于人群的队列研究。

PLoS Med. 2019 Oct 21;16(10):e1002930. doi: 10.1371/journal.pmed.1002930. eCollection 2019 Oct.

3

Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.血管加压素类似物输注的糖尿病患者中内皮血管性血友病因子的可用性和血小板功能

Diabetologia. 1982 Nov;23(5):452-5. doi: 10.1007/BF00260961.